Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03407469 · ClinicalTrials.gov registry record
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
A clinical trial of Cancer-related Venous Thromboembolism, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 260
- Enrollment target
- 4
- Study locations
NCT03407469 is a study of Cancer-related Venous Thromboembolism that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 260 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT03407469, a study of Cancer-related Venous Thromboembolism, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 260 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this research study is to learn about the quality of life, experiences with treatment, and healthcare costs of patients who are receiving long-term treatment for venous thromboembolism (VTE) that is related to cancer. This is an investigational study. Up to 260 participants will be enrolled in this multicenter study. Up to 170 will take part in MD Anderson.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
Study Locations (4)
Other
- Fundacion Valle del Lili - Cali
- Hospital German Trias i Pujol - Barcelona
Texas
- University of Texas MD Anderson Cancer Center - Houston
Carrer de Villarroel, 170
- Hospital Clinic - Barcelona
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2018-01-12 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03407469
The ClinicalTrials.gov registry entry for NCT03407469 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer-related Venous Thromboembolism appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT03407469 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Other, Texas, Carrer de Villarroel, 170.
Frequently Asked Questions
What is clinical trial NCT03407469 about?
NCT03407469 is a clinical study titled "Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization". The goal of this research study is to learn about the quality of life, experiences with treatment, and healthcare costs of patients who are receiving long-term treatment for venous thromboembolism (VTE) that is related to cancer. This is an investigational study. Up to 260 participants will be enro...
What is the current status of trial NCT03407469?
This trial is currently recruiting. The enrollment target is 260 participants. The study started on 2018-01-12. Estimated completion is 2026-12-31.
What conditions does trial NCT03407469 study?
This clinical trial studies the following conditions: Cancer-related Venous Thromboembolism.
What interventions are being tested in trial NCT03407469?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT03407469?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03407469 being conducted?
This trial has 4 study locations across Texas, Carrer de Villarroel, 170. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.